Latest filing published 03 Aug 2026 for GLAUKOS Corp, €76k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Leana Wen: trading record in brief
Filings by Leana Wen span 2 companies, the busiest being GLAUKOS Corp and UroGen Pharma Ltd. Between 1 March 2021 and 31 July 2026, the trades on record add up to 14 filings.
Every open-market trade on record is a sale: 1 sale worth €76k. Outside the open market, there are 12 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 3 August 2026 with an open-market sale (€76k) in GLAUKOS Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Leana Wen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 525 shares@ US$167.630.0009% mcap50.0% of flowCommon StockSEC:0001847598-26-000010:0
- 623 shares0Common StockSEC:0001847598-26-000002:0
- 2,000 sharesordinary sharesSEC:0001437749-25-036557:0
- 461 shares0Common StockSEC:0001415889-25-015160:0
- 1,716 shares0Common StockSEC:0001415889-24-015238:0
- 3,230 shares0Common StockSEC:0001415889-23-009297:0
- 1,572 shares0Common StockSEC:0001415889-23-000444:0
- 1,572 shares0Common StockSEC:0001415889-23-000440:0
- 4,364 shares0Common StockSEC:0001104659-22-068670:0
- 1,455 shares0Common StockSEC:0001104659-22-001666:0
- 2,382 shares0Common StockSEC:0001104659-21-077830:0
11 of 11 declarations
